CRYSTAL BENNETT: Open Payments
NPI 1770839953 · RAYVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,784 in 102 payments from 18 companies in 2025. Trend: 2023 $1,624 · 2024 $1,463 · 2025 $1,784
Food & beverage: $1,784
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $258 |
| E.R. Squibb & Sons, L.L.C. | 11 | $190 |
| ABBVIE INC. | 15 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $170 |
| Axsome Therapeutics, Inc. | 14 | $164 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| Alkermes, Inc. | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $83 |
| Janssen Pharmaceuticals, Inc | 3 | $81 |
Products named: AUSTEDO XR, COBENFY, CAPLYTA, Auvelity, VRAYLAR, FANAPT, ARISTADA, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
